chr9-121006922-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001735.3(C5):c.2404G>A(p.Val802Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 1,604,840 control chromosomes in the GnomAD database, including 166,241 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001735.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C5 | NM_001735.3 | c.2404G>A | p.Val802Ile | missense_variant | 19/41 | ENST00000223642.3 | NP_001726.2 | |
C5 | NM_001317163.2 | c.2422G>A | p.Val808Ile | missense_variant | 19/41 | NP_001304092.1 | ||
C5 | NM_001317164.2 | c.2404G>A | p.Val802Ile | missense_variant | 19/21 | NP_001304093.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C5 | ENST00000223642.3 | c.2404G>A | p.Val802Ile | missense_variant | 19/41 | 1 | NM_001735.3 | ENSP00000223642.1 |
Frequencies
GnomAD3 genomes AF: 0.365 AC: 55524AN: 151940Hom.: 12586 Cov.: 32
GnomAD3 exomes AF: 0.471 AC: 118467AN: 251326Hom.: 30016 AF XY: 0.484 AC XY: 65709AN XY: 135848
GnomAD4 exome AF: 0.451 AC: 655711AN: 1452782Hom.: 153644 Cov.: 31 AF XY: 0.458 AC XY: 331393AN XY: 723154
GnomAD4 genome AF: 0.365 AC: 55533AN: 152058Hom.: 12597 Cov.: 32 AF XY: 0.376 AC XY: 27909AN XY: 74324
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at